Holistic management of chronic obstructive pulmonary disease in primary care
Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Malaysia that is mainly preventable and treatable but unfortunately remains largely undiagnosed. Primary care providers play a vital role in screening the population at risk, making an early diagnosis and initiating prompt and appropriate therapy including smoking cessation to improve symptoms and quality of life of the COPD patient. Measures to prevent and treat exacerbations are also important to prevent further rapid decline in lung function and to reduce morbidity and mortality associated with the disease.
Gold Executive Committee. Pocket Guide to COPD Diagnosis, Management, and Prevention. A Guide for Healthcare Professional. The Global Initiative for Chronic Obstructive Lung Disease, 2010.
Murray CJ, Lopez AD. Alternative projection of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498-504.
Anto JM, Vermeire P, Vestboz J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J. 2001;17(5):982-94.
Malaysia Ministry of Health. National Health Morbidity Survey III. Institute of Public Health, Malaysia; 2006.
Regional COPD Working Group. COPD prevalence in 12 AsiaPacific countries and regions: projections based on the COPD prevalence estimation model. Respirology. 2003;8(2):192-8.
Clinical Practice Guidelines. Management of Chronic Obstructive Pulmonary Disease. 2nd ed. Ministry of Health Malaysia, 2009.
Todd DC, McIvor RA, Pugsley SO, et al. Approach to chronic obstructive pulmonary disease in primary care. Can Fam Physician. 2008;54(5);706-11.
Buffels J, Degryse J, Heyrman J, et al. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest. 2004;125(4):1394-9.
Barr RG, Celli BR, Martinez FJ, et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med. 2005;118(12):1415.
Aggarwal AN, Gupta D, Jindal SK. The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor. Chest. 2006;130(5):1454–61.
Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434-40.
Fletcher CM, Elmes PC, Fairbairn AS, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ. 1959;2(5147):257-66.
Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-12.
Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543-54.
Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775-89.
Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.Thorax. 2002;57(10):847-52.
Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Respir Crit Care Med. 1996;154(4 Pt ):959-67.
van der Meer RM, Wagena E, Ostelo RWJG, et al. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2003;(2):CD002999.
Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Int Med. 2003;163(5):585-91.
van Manen JG, Bindels PJ, Dekker FW, et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57(5):412-6.
Yamanaka Y, Ishikawa A, Miyasaka T, et al. The effect of unsupervised home exercise program for patients with chronic obstructive pulmonary disease. Nippon Ronen Igakkai Zasshi. 2009;46(2):154-9.
Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalizations, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130(5):397-403.
Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest. 2004;125(6):2011-20.
Schols AM, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1791-7.
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981;1(8222):681-6.
Ram FS, Sestini P. Regular inhaled short acting beta2 agonists for the management of stable chronic obstructive airway disease: Cochrane systemic review and meta-analysis. Thorax. 2003;58(7):580-4.
Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of flucticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000;320(7245):1297-303.
Ismail TS. Exacerbation of chronic obstructive pulmonary disease. Med J Malaysia. 2009;64(3):250-5.
Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med. 1999;340(25):1941–7.
Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196-204.